Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease

Archives of Pediatrics and Adolescent Medicine

Volumn 154, Issue 7, 2000, Pages 694-699

  Han, Ra K ^a   Silverman, Earl D ^b   Newman, Alice ^a   McCrindle, Brian W ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FEVER; HEART DISEASE; HEART VENTRICLE FAILURE; HUMAN; IMMUNOTHERAPY; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERICARDIAL EFFUSION; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033946004     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.154.7.694     Document Type: Article

References (9)

1. Kato H, Koike S, YokoyamaT. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics. 1979;63:175-179.
2. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
3. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
4. Sundel RP, Bums JC, Baker A, Beiser AS, Newburger JW. Gamma globulin retreatment in Kawasaki disease. J Pediatr. 1993;123:657-659.
5. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulinresistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996; 128:146-149.
6. Nonaka Z, Maekawa K, Okabe T, Eto Y, Kubo M. Randomized controlled study of intravenous prednisolone and gammaglobulin treatment in 100 cases with Kawasaki. In: Kato H, ed. Proceedings of the Fifth International Symposium on Kawasaki Disease; 22-25 May 1995; Fukuoka, Japan. Amsterdam, the Netherlands: Elsevier; 1995:328-331.
7. Shinohara M, Katsuhiko S, TomomasaT, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr. 1999;135:465-469.
8. Yanagawa H, Nakamura Y, Sakata K, Yashiro M. Use of intravenous gamma globulin for Kawasaki disease: effects on cardiac sequelae. Pediatr Cardiol. 1997;18: 19-23.
9. Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055-1058.